Ensuring timely antibody supply during the COVID-19 pandemic - contact us for solutions

Rat Anti-Mouse CD45RB-SPRD (C363.16A)

Cat. No.:
1675-13
PE/CY5 (SPRD) Anti-Mouse CD45RB antibody for use in flow cytometry assays.
$215.00
Size Price (USD) Quantity
0.1 mg $215.00
More Information
Clone C363.16A
Isotype Rat IgG2aκ
Isotype Control Rat IgG2a-SPRD (KLH/G2a-1-1)
Specificity Mouse CD45RB
Description CD45RB represents an exon B-dependent form of CD45 glycoprotein. It is expressed at high density on peripheral B cells, the suppressor/cytotoxic subpopulation of T lymphocytes, a subset of helper T cells, most thymocytes, and at low density on macrophages and dendritic cells.
Immunogen Cloned mouse Th cell line
Conjugate SPRD (R-phycoerythrin/Cyanine 5)
Buffer Formulation Phosphate buffered saline containing < 0.1% sodium azide and a stabilizer
Clonality Monoclonal
Concentration 0.1 mg/mL
Volume 1.0 mL
Recommended Storage 2-8°C; Avoid exposure to light; Do not freeze
Trademark Information Spectral Red® is a registered trademark of Southern Biotechnology Associates, Inc.
Spectral Red® is a PE/CY5 tandem conjugate
Cy® is a registered trademark of Global Life Sciences Solutions Germany GmbH
Applications Flow Cytometry – Quality tested 1,2,4
Separation – Reported in literature 3

RRID Number AB_2795136
Gene ID 19264 (Mouse)
Gene ID Symbol Ptprc (Mouse)
Gene ID Aliases loc; B220; Cd45; L-CA; Ly-5; T200; CD45R; Lyt-4
UniProt ID P06800 (Mouse)
UniProt Name PTPRC_MOUSE (Mouse)

Certificate of Analysis Lookup

Enter the Catalog Number and Lot Number for the Certificate of Analysis you wish to view


Need help with this product?
or call 800.722.2255
  1. 1. Johnson P, Greenbaum L, Bottomly K, Trowbridge IS. Identification of the alternatively spliced exons of murine CD45 (T200) required for reactivity with B220 and other T200-restricted antibodies. J Exp Med. 1989;169:1179-84. (FC)
  2. 2. Hathcock KS, Laszlo G, Dickler HB, Sharrow SO, Johnson P, Trowbridge IS, et al. Expression of variable exon A-, B-, and C-specific CD45 determinants on peripheral and thymic T cell populations. J Immunol. 1992;148:19-28. (FC)
  3. 3. Farber DL, Acuto O, Bottomly K. Differential T cell receptor-mediated signaling in naive and memory CD4 T cells. Eur J Immunol. 1997;27:2094-101. (Sep)
  4. 4. Borlado LR, Redondo C, Alvarez B, Jimenez C, Criado LM, Flores J, et al. Increased phosphoinositide 3-kinase activity induces a lymphoproliferative disorder and contributes to tumor generation in vivo. FASEB J. 2000;14:895-903. (FC)